Medicenna Therapeutics's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Medicenna Therapeutics (NASDAQ:MDNA) is set to release its latest quarterly earnings report on August 9, 2023. Analysts estimate an earnings per share (EPS) of $-0.05. The company's past performance shows a pattern of beating EPS estimates, which has led to share price increases. However, the stock has been on a downward trend, with shares down 59.82% over the last 52-week period.
August 08, 2023 | 5:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Medicenna Therapeutics is expected to report an EPS of $-0.05 in its upcoming earnings. Despite past EPS beats, the stock has been on a downward trend, which may influence investor sentiment.
Medicenna Therapeutics has a history of beating EPS estimates, which has previously led to share price increases. However, the overall downward trend of the stock, with shares down 59.82% over the last 52-week period, may overshadow any positive impact from an earnings beat. This could lead to a negative short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100